SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: 2014 Strategies for the Italian Clinical Chemistry and Immunodiagnostics Market

[February 07, 2014]

Research and Markets: 2014 Strategies for the Italian Clinical Chemistry and Immunodiagnostics Market

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/jv62hd/2014_strategies) has announced the addition of the "2014 Strategies for the Italian Clinical Chemistry and Immunodiagnostics Market" report to their offering.

2014 Strategies for the Italian Clinical Chemistry and Immunodiagnostic Market is a new strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the German market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.


The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Strategic Recommendations

  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.

Competitive Assessments

  • Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
  • The companies analyzed in the report include Abbott, AdnaGen, Agilent (News - Alert), Alere, Beckman Coulter/Danaher, Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin, Eiken, Fujirebio/Innogenetics, IL, Kyowa Medex, Ortho-Clinical Diagnotics, Roche, Siemens (News - Alert), Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE.

For more information visit http://www.researchandmarkets.com/research/jv62hd/2014_strategies


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy